Conditions: Carcinoma, Renal Cell; Head and Neck Neoplasm; Skin Neoplasms; Microsatellite Instability; Penile Neoplasms
Intervention: Drug: Nivolumab
Sponsors: UNICANCER; National Cancer Institute, France; Ligue contre le cancer, France; Bristol-Myers Squibb
Not yet recruiting - verified January 2017
Predicting Mortality of Ruptured Abdominal Aortic Aneurysms in the Era of Endovascular Repair - In the endovascular era where both open and endovascular treatment are offered for the treatment of a ruptured abdominal aortic aneurysm (rAAA), three vari...